Application of ChatGPT in Routine Diagnostic Pathology: Promises, Pitfalls, and Potential Future Directions.
Application of ChatGPT in Routine Diagnostic Pathology: Promises, Pitfalls, and Potential Future Directions. Adv Anat Pathol. 2023 Jul 27.
PMID: 37501529
International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial Carcinomas.
International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial Carcinomas. Am J Surg Pathol. 2023 Jun 29.
PMID: 37382156
The influence of the "cancer" label on perceptions and management decisions for low-grade prostate cancer.
The influence of the "cancer" label on perceptions and management decisions for low-grade prostate cancer. J Natl Cancer Inst. 2023 Jun 07.
PMID: 37285311
Point-Counterpoint: Grade Group 1 (Gleason Score 6) Prostate Cancer Should Be Renamed to Improve Public Health: Pathologists' Perspective.
Point-Counterpoint: Grade Group 1 (Gleason Score 6) Prostate Cancer Should Be Renamed to Improve Public Health: Pathologists' Perspective. J Urol. 2023 Jul; 210(1):23-25.
PMID: 37126310
Physician Perception of Grade Group 1 Prostate Cancer.
Physician Perception of Grade Group 1 Prostate Cancer. Eur Urol Focus. 2023 Apr 26.
PMID: 37117112
Renaming Grade Group 1 Prostate "Cancer" From a Pathology Perspective: A Call for Multidisciplinary Discussion.
Renaming Grade Group 1 Prostate "Cancer" From a Pathology Perspective: A Call for Multidisciplinary Discussion. Adv Anat Pathol. 2023 Apr 17.
PMID: 37072903
Reply to X. Farré et al.
Reply to X. Farré et al. JCO Glob Oncol. 2023 Apr; 9:e2300015.
PMID: 37099737
Reply to M. Baboudjian et al.
Reply to M. Baboudjian et al. J Clin Oncol. 2023 Mar 01; 41(7):1493-1494.
PMID: 36459669
Blood Prostate-specific Antigen by Volume of Benign, Gleason Pattern 3 and 4 Prostate Tissue.
Blood Prostate-specific Antigen by Volume of Benign, Gleason Pattern 3 and 4 Prostate Tissue. Urology. 2022 12; 170:154-160.
PMID: 35987380
Updates in Grading of Renal Cell Carcinomas Beyond Clear Cell Renal Cell Carcinoma and Papillary Renal Cell Carcinoma.
Updates in Grading of Renal Cell Carcinomas Beyond Clear Cell Renal Cell Carcinoma and Papillary Renal Cell Carcinoma. Adv Anat Pathol. 2022 May 01; 29(3):117-130.
PMID: 35275846